Published • loading... • Updated
Morning Business Report: Medicare Obesity Coverage Drives GLP-1 Use as Disney Promotions Boost Park Attendance
Roughly 70% of the new patients are taking Lilly medicines, with Zepbound emerging as the main beneficiary, CEO Dave Ricks said.
Summary by 41NBC News | WMGT-DT
6 Articles
6 Articles
Morning Business Report: Medicare obesity coverage drives GLP-1 use as Disney promotions boost park attendance
(LILAMAX)- Eli Lilly CEO Dave Ricks says 700,000 new seniors have started GLP-1 treatments since Medicare coverage for obesity drugs launched in July. In an interview with CNBC, Ricks said about 70% of those patients are taking Eli Lilly medications. The expanded coverage has helped seniors with a high body mass index and preexisting conditions such as hypertension and prediabetes, as well as those who have previously experienced a heart attack …
According to CNBC, CEO of Eli Lilly claims that 700,000 new beneficiaries of Medicare have started GLP-1 since July and 70% use medicines from the company
Coverage Details
Total News Sources6
Leaning Left2Leaning Right0Center2Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
